HTBX insider filings
HEAT BIOLOGICS, INC. — 18 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-01-03. Screen HTBX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for HTBX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — HEAT BIOLOGICS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-01-03 | 4 | Smith Edward B III — Director | Other (J): 32,467 (derivative) @ $0 · Grant/award (A): 32,467 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | Wolf Jeffrey Alan — Chief Executive Officer, Director | Other (J): 231,987 (derivative) @ $0 · Grant/award (A): 231,987 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | MONAHAN JOHN J — Director | Other (J): 32,467 (derivative) @ $0 · Grant/award (A): 32,467 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | PRENDERGAST JOHN K A — Director | Other (J): 129,820 (derivative) @ $0 · Grant/award (A): 129,820 (derivative) @ $0 | EDGAR |
| 2021-12-15 | 4 | Ostrander William L. — CFO/Corp Secy | Grant/award (A): 68,807 (derivative) @ $0 | EDGAR |
| 2021-12-15 | 4 | Smith Edward B III — Director | Grant/award (A): 32,467 (derivative) @ $0 | EDGAR |
| 2021-12-15 | 4 | Wolf Jeffrey Alan — Chief Executive Officer, Director | Grant/award (A): 246,305 @ $0 · Grant/award (A): 393,761 (derivative) @ $0 | EDGAR |
| 2021-12-15 | 4 | MONAHAN JOHN J — Director | Grant/award (A): 32,467 (derivative) @ $0 | EDGAR |
| 2021-12-15 | 4 | PRENDERGAST JOHN K A — Director | Grant/award (A): 129,820 (derivative) @ $0 | EDGAR |
| 2021-05-18 | 4 | PRENDERGAST JOHN K A — Director | Sale (S): 35,000 @ $5.87 | EDGAR |
| 2021-01-06 | 4 | Ostrander William L. — CFO/Corp Secy | Grant/award (A): 51,487 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | Smith Edward B III — Director | Grant/award (A): 65,217 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | Wolf Jeffrey Alan — Chief Executive Officer, Director | Grant/award (A): 288,100 @ $0 · Grant/award (A): 147,980 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | MONAHAN JOHN J — Director | Grant/award (A): 65,217 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | PRENDERGAST JOHN K A — Director | Grant/award (A): 138,272 @ $0 | EDGAR |
| 2020-11-13 | 4 | Smith Edward B III — Director | Sale (S): 103,304 @ $1.03 | EDGAR |
| 2020-08-25 | 4 | Wolf Jeffrey Alan — Chief Executive Officer, Director | Grant/award (A): 1,412,100 (derivative) @ $0 | EDGAR |
| 2020-08-14 | 4 | Ostrander William L. — VP Finance/Corp Secy | Option exercise (M): 15,625 @ $0.52 · Tax withholding (F): 4,440 @ $1.83 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
Recent 8-K events — HEAT BIOLOGICS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-04-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-04-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K/A | 2.01 — Completion of Acquisition or Disposition of Assets 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-29 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=HTBX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs